Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation
Bardees M. Foda(National Research Centre), Richard R. Neubig(Michigan State University)
Cited by 11
Related Papers
Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells
|Journal of Biological Chemistry|2002|126
Cardiotonic Steroids Stabilize Regulator of G Protein Signaling 2 Protein Levels
|Molecular Pharmacology|2012|33
FBXO44-Mediated Degradation of RGS2 Protein Uniquely Depends on a Cullin 4B/DDB1 Complex
|PLoS ONE|2015|33
Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells
|Molecular Pharmacology|2021|16